Culturing and Transfecting HeLa and RPE1 Cells
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : University of Warwick
Variable analysis
- SiRNA oligonucleotides (53 nM)
- ZM447439 (2 µM, 30 min treatment)
- Taxol (100 nM, 1 h treatment)
- Cellular response to siRNA knockdown and drug treatments (not explicitly specified)
- HeLa-Kyoto (K) cells grown in a humidified incubator at 37°C and 5% CO2 in DMEM (Gibco) containing 10% FCS, 100 U/ml penicillin, and 100 µg/ml streptomycin supplemented with 0.1 µg/ml puromycin (Invitrogen) for maintenance of the eGFP-CENP-A cell line
- HeLa H2B-GFP cell line maintained in nonselective medium
- HTERT-RPE1 eGFP-CENP-A cell line maintained in DMEM/F-12 medium containing 10% FCS, 2.3 g/l sodium bicarbonate, 100 U/ml penicillin, and 100 µg/ml streptomycin
- Control siRNA oligonucleotide sequence: 5'-GGACCUGGAGGUCUGCUGU-3'
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!